Cited by 669Virus-based gene therapy researchImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 132 of the 134 references it cites were found in a registry or an index.

Adenoviruses as vaccine vectors

Open access

Tatsis, Nia, Ertl, Hildegund C.J.·2004·Molecular Therapy

DOI 10.1016/j.ymthe.2004.07.013PMC PMC7106330

Open this paper in CoChat — free account

Abstract

Adenoviruses have transitioned from tools for gene replacement therapy to bona fide vaccine delivery vehicles. They are attractive vaccine vectors as they induce both innate and adaptive immune responses in mammalian hosts. Currently, adenovirus vectors are being tested as subunit vaccine systems for numerous infectious agents ranging from malaria to HIV-1. Additionally, they are being explored as vaccines against a multitude of tumor-associated antigens. In this review we describe the molecular biology of adenoviruses as well as ways the adenovirus vectors can be manipulated to enhance their efficacy as vaccine carriers. We describe methods of evaluating immune responses to transgene products expressed by adenoviral vectors and discuss data on adenoviral vaccines to a selected number of pathogens. Last, we comment on the limitations of using human adenoviral vectors and provide alternatives to circumvent these problems. This field is growing at an exciting and rapid pace, thus we have limited our scope to the use of adenoviral vectors as vaccines against viral pathogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2004.07.013

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“3 , are now available [61] [62] [63] [64] .”
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033
Self-citation
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655

Show all 134 references

Research works printed but not linked: 1

Fisher, 2000, Protection and retargeting of adenovirus using a multifunctional hydrophilic polymer, Mol. Ther., 1S, 57

Sorted by citations

Items 601–665 of 665

Controlling Transgene Expression in the Central Nervous System For MRI-Guided Focused Ultrasound Delivery of Adeno-Associated Virus
Weber‐Adrian, D. (2017) · TSpace (University of Toronto)
Vaccines for Emerging Viruses—A Comprehensive Update
Hewson, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-71165-8_29
Development of leading first-generation vaccines against SARS-CoV-2
Perera, P., & Perera, L. P. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104841
Breaking Entry- and Species Barriers: LentiBOOST® Plus Polybrene Enables High Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5Preprint
Strack, A., Deinzer, A., Thirion, C., Schrödel, S., Dörrie, J., Sauerer, T., Steinkasserer, A., & Knippertz, I. (2021) · Research Square · doi:10.21203/rs.3.rs-701427/v1
Vaccinations, The Journey So Far and The Road Ahead
Chattopadhyay, S. (2021) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2021.13.001884
A COVID-19 megelőzésére szolgáló vakcinák összetétele, működési elve
Deli, G., Pataki, Á., Emődy-Kiss, B., Takács, E., Papp, S., & Fent, J. (2020) · Honvédorvos · doi:10.29068/ho.2020.3-4.5-23
Adverse effects of vaccinations and potential therapies against COVID-19
Wasiak, K., & Rieske, P. (2022) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2022.114392
Long-Term Protective Immunity Induced Against Trypanosoma cruzi Infection After Vaccination with Recombinant Adenoviruses Encoding Amastigote Surface Protein-2 and Trans -Sialidase
Machado, A. V., Cardoso, J. E., Claser, C., Rodrigues, M. M., Gazzinelli, R. T., & Bruña–Romero, O. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-239
Correction: Antibody Responses against Xenotropic Murine Leukemia Virus-Related Virus Envelope in a Murine Model
Makarova, N., Zhao, C., Zhang, Y., Bhosle, S. M., Suppiah, S., Rhea, J. M., Kozyr, N. L., Arnold, R. S., Ly, H., Molinaro, R. J., et al. (2011) · PLoS ONE · doi:10.1371/annotation/913fdc1e-877e-4c70-ac20-761d2d72400d
Pharmacodynamic Evaluation: Gene Therapy
Grandchamp, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-56637-5_51-1
The Mechanism, Progress, and Potential Problems behind Different Types of COVID-19 Vaccines
Wang, Y., & Wu, Z. (2022) · International Conference on Biotechnology, Life Science and Medical Engineering (BLSME) · doi:10.23977/blsme.2022050
Different Platforms, Immune Response Modulators and Challenges in SARS-CoV-2 Vaccination
Portilho, A. I., Correa, V. A., Gaspar, E. B., & Gaspari, E. D. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_26
Development of recombinant adenovirus vector herpes zoster vaccine production process using perfusion strategy with tangential flow filtration system
Sun, Y., Feng, K., Nie, J., Huang, L., Liu, Y.-P., & Bai, Z. (2022) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.7268
Studies on the enzymatic specificity of diguanylate cyclases domains and the production of new second messengers
Arévalo, S. J. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-26102022-112347
Nanotechnology in COVID-19 Vaccines
Jain, A., & Sharma, S. (2022) · doi:10.2991/978-94-6463-020-6_3 · Cited by 6
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome
Gillot, C., Favresse, J., Maloteau, V., Mathieux, V., Dogné, J., Mullier, F., & Douxfils, J. (2022) · Vaccines · doi:10.3390/vaccines10122056
Recombinant Vaccines: The Revolution Ahead
Nayak, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_8
Genetic Engineering of Nonhuman Primate Models for Studying Neurodevelopmental Disorders
Suresh, R., Megagiannis, P., Chen, H., Landman, R., Sharma, J., & Zhou, Y. (2022) · Neuromethods · doi:10.1007/978-1-0716-2569-9_12
Comparison of SARS-CoV2 IgG Antibody Levels in Health Workers with and without a History of COVID-19 Infection after Heterologous Vaccination at Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
Puspalina, F., Kurniati, N., Salim, E. M., Yuniza, & Ahmad, Z. (2023) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v6i16.713
Gene Therapy and Gene Editing
Assaf, B. T., Harper, C. G., & Phillips, J. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821047-5.00034-8
Data from Antibody-Dependent Natural Killer Cell–Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors
Triulzi, C., Vertuani, S., Curcio, C., Antognoli, A., Seibt, J., Akusjärvi, G., Wei, W.-Z., Cavallo, F., & Kiessling, R. W. (2023) · doi:10.1158/0008-5472.c.6500724
Data from An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
Hartman, Z. C., Wei, J.-P., Osada, T., Glass, O., Lei, G., Yang, X.-Y., Peplinski, S., Kim, D.-W., Xia, W., Spector, N. L., et al. (2023) · doi:10.1158/1078-0432.c.6518551
Data from An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
Hartman, Z. C., Wei, J.-P., Osada, T., Glass, O., Lei, G., Yang, X.-Y., Peplinski, S., Kim, D.-W., Xia, W., Spector, N. L., et al. (2023) · doi:10.1158/1078-0432.c.6518551.v1
Data from Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Chiaro, J., Kasanen, H. H. E., Whalley, T., Capasso, C., Grönholm, M., Feola, S., Peltonen, K., Hamdan, F., Hernberg, M., Mäkelä, S., et al. (2023) · doi:10.1158/2326-6066.c.6550583
Historical Progression from Nerve Tissue-Based Rabies Vaccines to Recombinant Biologics for Humans and Companion Animals
Ertl, H. C. J. (2023) · Fascinating life sciences · doi:10.1007/978-3-031-25052-1_6
Self-citation
Applications of Viral Vectors for Cancer Immunotherapy
Lundstrom, K. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_198-1
The Impact of Sputnik SARS-CoV-2 Vaccines on Antibody Response in the Egyptian Population
Ismail, G., Abdelhamid, D. H., Mostafa, M. S., Fahim, N. A. E.-D. M., Elshafei, A., Abdelghaffar, H., Omar, N. N., Taher, O., & Asker, M. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11163
Recent Advances in Vaccine Technology for Viral Infection Management: A Spotlight on Next-Generation Vaccines and Nucleic Acid-Based Platforms
Ali, M. Z., Anwar, Y., Abbas, A., Ain, N. U., Khalid, Z., Sattar, A., Usman, M., Nazir, A., & Zeb, S. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023175261
Adenovirus VA RNAs impair maturation of primary microRNA
Kim, J. H., Lee, C. H., & Lee, S. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3564
Genetic-Based Vaccine Vectors
Weiner, D. B., Jansen, K. U., & Villafana, T. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00068-2
Adenoviruses
Zhang, Q. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00165-9
A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients
Zhang, Z., Yang, W., Chen, Z., Chi, H., Wu, S., Zheng, W., Jin, R., Wang, B., Wang, Y., Huo, N., et al. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100603
Quantification of IgG antibodies against SARS-CoV-2 on the staff of the Rawson Hospital, Córdoba Province, Argentina
Alvarado, C. D. B., Zini, C., & Collino, C. (2023) · Revista Bioquímica y Patología Clínica · doi:10.62073/bypc.v87i3.246
What is CRISPR?
Du, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23865-9.00002-2
Human Adenovirus (HAdV) mediated inhibition of the tumor suppressor p53 is controlled by SUMOylation of the viral E2A/DBP proteinPreprint
Stubbe, M., Stubbe, H. C., Mai, J., Plank, V., Hofmann, S., Göttig, L., Günther, T., Grundhoff, A. T., Krebs, S., Groitl, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.07.636424
Harnessing nc886 to overcome immune and apoptotic barriers in adenoviral gene therapy
Hammad, M., & Ashour, H. M. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102493
Adenovirus vectored veterinary vaccines
Dar, F., Kulanayake, S., Ndlovu, S., Chand, S., Singh, B., & Tikoo, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-89821-8.00004-8
Manufacturing and upscaling
Cody, J. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-89821-8.00026-7
Seroprevalence of Neutralizing Antibodies in Healthy Adults, in Mexico, Against Human and Simian Adenovirus Types
López, R. E., Alemán, M. V., Torres-Flores, J. M., Pérez‐Llano, Y., Cabrera-Gaytán, D. A., Santacruz-Tinoco, C. E., Alvarado-Yaah, J. E., Hernández, Y. M. A., Martínez-Miguel, B., Muñoz‐Medina, J. E., et al. (2025) · Viruses · doi:10.3390/v17091184
Adenovirus-based vaccines transduce and activate human Langerhans cellsPreprint
Gerber-Tichet, E., Ngo, T. H. G., Blanchet, F. P., & Kremer, E. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.06.680090
Applications of Viral Vectors for Cancer Immunotherapy
Lundstrom, K. H. (2025) · Springer eBooks · doi:10.1007/978-3-032-00767-4_198
Adenovirus Serotype 26 Cultivation on a Production Scale: Optimization of Conditions
Kirilin, A. V., Гузов, Е. А., Саповская, В. В., Хоромская, А. А., Сечин, Е. Н., Ерхов, А. В., Sarbasov, A. B., Романова, П. Ю., Vasiliev, Y. M., Колышкин, В. М., et al. (2025) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683825700115
Gene Transfer Studies Using Mouse Models
Pergolizzi, R. G., & Crystal, R. G. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50026-1
Precise and multifunctional conjugates for targeted siRNA delivery
Dohmen, C. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14318
Purification of complex biopharmaceuticals with new processes, advanced analytics and computer-aided process design tools
Martins, D. L. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Additional file 1 of Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
Müller, M. K., Volzke, J., Subin, B., Müller, S. C., Sombetzki, M., Reisinger, E. C., & Müller‐Hilke, B. (2022) · Figshare · doi:10.6084/m9.figshare.18666522
Additional file 1 of In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging
Fink, C., Gevaert, J. J., Barrett, J. W., Dikeakos, J. D., Foster, P. J., & Dekaban, G. A. (2024) · Figshare · doi:10.6084/m9.figshare.26605774
An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis
Dold, C., Silva-Reyes, L., Kim, Y. C., Blackwell, L., Campos, P., Linder, A., Bridges-Webb, A., Kasanyinga, M., López‐Camacho, C., Challis, A., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.02.036
Vaccination Potential Of Adenoviral Vectors Displaying Heterologous Epitopes In Their Capsid Proteins
Anchim, A. (2016) · theses.fr (ABES) · doi:10.70675/d10fb830z5afez4e17zb40fz3b23249344dc
Stratégies de vaccination basées sur l’exposition de peptides ou de protéines à la surface de particules virales : modèles de l’adénovirus 5 et du bactériophage T5
Ramdani, L. (2019) · theses.fr (ABES) · doi:10.70675/f969a6a8z33edz44c5zaa78z16d63165e115
Développement d'une stratégie Cheval de Troie dans le traitement du carcinome hépatocellulaire
Nayagom, B. (2019) · theses.fr (ABES) · doi:10.70675/780d49f6zde47z4ff1z9bc4z7e014070104c
Comparaison de surface épitopiques en fonction de différentes conditions et calculs d’affinité protéine-protéine par méthodes bio-informatiques
Berthier, L. (2021) · theses.fr (ABES) · doi:10.70675/f780f24fzc468z4ab1z8f04z228af1b56a77
Towards the development of a gene therapy for Pompe disease : Characterization of the immune phenotype in Pompe disease and comparison of the therapeutic potential of gene therapy with the current standard of care
Verdera, H. C. (2019) · theses.fr (ABES) · doi:10.70675/3d2d8524z211ez4408zbdfbz56c065f452a1
Rôle des cellules lymphoïdes innées humaines (ILC) dans la réponse immunitaire contre les adénovirus chez un hôte avec une immunité préexistante
Paris, O. (2021) · theses.fr (ABES) · doi:10.70675/63a8ee5ezfe9ez441fz95bbz9d42d830efda
Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation
NAKATANI, H., Tachibana, M., Onishi, R., Nakagaki, T., Ishii, K. J., Shimizu, K., Sakurai, F., & Mizuguchi, H. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201742
Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain
Siniavin, A. E., Gushchin, V. A., Kuznetsova, N. A., Russu, L. I., Marchuk, E. V., Kleymenov, D. A., Nikiforova, M. A., Zubkova, O. V., Popova, O. D., Викторовна, В. И., et al. (2026) · Problems of Virology · doi:10.36233/0507-4088-353
Gene therapy and its role in modern drug delivery
Gupta, K., Kaushik, N., Singh, A. K., Sharma, V., Biswas, T., Siddiqui, T., & Vinchurkar, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40620-1.00015-7
Study on fungi, viruses and protozoa
Preeti, Kajal, A., Malik, R., Sehrawat, R., & Gahlot, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-817534-7.00003-3
Recombinant human adenovirus type 5-vectored vaccine expressing avian reovirus σC protein protects against prevalent genotype I avian reovirus in chickens
Cui, X., Song, Z., Zhou, D., Yang, L., Chen, H., Zhang, H., & Cheng, Z. (2026) · Poultry Science · doi:10.1016/j.psj.2026.107495
Type of Vaccines and their Preparation
Abraham, S., Shwetha, K., & Furtado, S. C. (2026) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-032-29006-9_3
Dual-expression-site fowl adenovirus 4 (FAdV-4) with high viral titer: a promising viral vector for multivalent poultry vaccines
Tang, Z., Liu, W., Xu, B., Feng, D., Liu, S., Fan, W., Song, S., & Yan, L. (2026) · Veterinary Research · doi:10.1186/s13567-026-01820-z
Bovine Adenovirus 3-Based Viral Vectors for Veterinary Vaccine Development: Progress, Limitations, and Future Directions
Sthitmatee, N., Varinrak, T., & Kreausukon, K. (2026) · Veterinary Sciences · doi:10.3390/vetsci13090850
Upstream process optimization and its critical role in chimpanzee adenoviral vector clinical drug development: lessons learned from VRON-0200 manufacturing
Haut, L. H., Bennett, J., & MacDonald, P. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1934410
Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity
Hanifehnezhad, A., Öztop, S., Tavukçuoğlu, E., Tanyeri, Y., Yoyler, E., Gökçe, G., Unal, N., Bozkır, A., Karaoğlu, T., Esendağlı, G., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-59094-6
An Integrated Modeling Framework for Industrial Vaccine Manufacturing Based on Dynamic Bioprocess Simulation and Techno-Economic Analysis
Niño, L., & Gelves, G. (2026) · South African Journal of Chemical Engineering · doi:10.1016/j.sajce.2026.101037

Authors: Tatsis, N., & Ertl, H. C. J.
Affiliations: The Wistar Institute (US)
Corresponding author: Ertl, Hildegund C.J.
ORCID: Ertl, Hildegund C.J.
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2004-10
Volume: 10
Issue: 4
Pages: 616-629
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1016/j.ymthe.2004.07.013
PMC: PMC7106330
OpenAlex: W1972258033
Cited by: 669
References: 134
Citations by year: 2026: 16 · 2025: 28 · 2024: 31 · 2023: 60 · 2022: 58 · 2021: 69 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 24 · 2014: 21 · 2013: 28 · 2012: 23
FWCI: 3.15
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4389 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: adenoviral vector, vaccine vectors, subunit vaccine, viral vaccines, innate immune response, adaptive immune response, transgene expression, HIV-1 vaccine, malaria vaccine, tumor-associated antigens
MeSH terms: Adenoviridae, Adenoviridae Infections, Genes, Viral, Genetic Vectors, Humans, Peptides, Viral Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adenoviruses as vaccine vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks